Identification of needs of patients with multiple myeloma: a questionnaire-based study in Israeli patients.

IF 1.7 4区医学 Q3 HEMATOLOGY

Acta Haematologica Pub Date : 2025-06-24 DOI:10.1159/000547025

Ilana Levy Yurkovski, Shira Ben-Dov, Varda Shoam, Micha Yuz, Noa Lavi

{"title":"Identification of needs of patients with multiple myeloma: a questionnaire-based study in Israeli patients.","authors":"Ilana Levy Yurkovski, Shira Ben-Dov, Varda Shoam, Micha Yuz, Noa Lavi","doi":"10.1159/000547025","DOIUrl":null,"url":null,"abstract":"Purpose: Multiple myeloma is an incurable chronic malignant disease. The disease itself and its treatment impair quality-of-life (QoL), yet there is no data regarding the biopsychosocial needs of patients in the era of new treatments. In the current study, we aimed to identify the biopsychosocial needs of patients with multiple myeloma.Methods: This is a descriptive study on patients with multiple myeloma in Israel in 2024. The information was based on a questionnaire examining physical, psychological and social needs filled out by myeloma patients. We analyzed the main impairments of QoL and what affected them, the main supporter in dealing with the disease, psychosocial needs reported by the patients and the difficulties in dealing with such difficulties.Results: The main symptom reported by multiple myeloma patients was fatigue. The number of treatment lines worsened QoL (Unstandardized coefficient: 0.987, 95% CI: 0.284; 1.691, p=0.006). The patient's partner mostly helped in dealing with the disease (72.7%). The most desired type of support was assistance in accessing rights (median 5, IQR 3-5), however one third did not use the support services offered to them. 48% of the patients talked to their doctor about the struggle and the accompanying difficulties.Conclusion: Myeloma patients report various impairments in the biopsychosocial components of QoL. Although supportive services are offered, adjustments must be made to optimally meet patients' needs. Further studies should test the effectiveness of different interventions on the biopsychosocial components of the QoL of these patients in the era of new drugs.","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"1-15"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Multiple myeloma is an incurable chronic malignant disease. The disease itself and its treatment impair quality-of-life (QoL), yet there is no data regarding the biopsychosocial needs of patients in the era of new treatments. In the current study, we aimed to identify the biopsychosocial needs of patients with multiple myeloma.

Methods: This is a descriptive study on patients with multiple myeloma in Israel in 2024. The information was based on a questionnaire examining physical, psychological and social needs filled out by myeloma patients. We analyzed the main impairments of QoL and what affected them, the main supporter in dealing with the disease, psychosocial needs reported by the patients and the difficulties in dealing with such difficulties.

Results: The main symptom reported by multiple myeloma patients was fatigue. The number of treatment lines worsened QoL (Unstandardized coefficient: 0.987, 95% CI: 0.284; 1.691, p=0.006). The patient's partner mostly helped in dealing with the disease (72.7%). The most desired type of support was assistance in accessing rights (median 5, IQR 3-5), however one third did not use the support services offered to them. 48% of the patients talked to their doctor about the struggle and the accompanying difficulties.

Conclusion: Myeloma patients report various impairments in the biopsychosocial components of QoL. Although supportive services are offered, adjustments must be made to optimally meet patients' needs. Further studies should test the effectiveness of different interventions on the biopsychosocial components of the QoL of these patients in the era of new drugs.

查看原文本刊更多论文

确定多发性骨髓瘤患者的需求：一项基于问卷的以色列患者研究。

目的：多发性骨髓瘤是一种无法治愈的慢性恶性疾病。疾病本身及其治疗损害生活质量（QoL），但没有关于患者在新治疗时代的生物心理社会需求的数据。在目前的研究中，我们旨在确定多发性骨髓瘤患者的生物心理社会需求。方法：这是一项对2024年以色列多发性骨髓瘤患者的描述性研究。这些信息是基于骨髓瘤患者填写的生理、心理和社会需求调查问卷。我们分析了生活质量的主要障碍及其影响因素、处理疾病的主要支持因素、患者报告的心理社会需求以及处理这些困难的困难。结果：多发性骨髓瘤患者报告的主要症状为疲劳。处理品系数量使生活质量恶化(非标准化系数：0.987,95% CI: 0.284；1.691, p = 0.006)。患者的伴侣主要帮助处理疾病（72.7%）。最期望的支持类型是获得权利方面的协助（中位数为5，IQR 3-5），但三分之一的人没有使用向他们提供的支持服务。48%的病人向他们的医生讲述了挣扎和伴随的困难。结论：骨髓瘤患者报告生活质量的各种生物心理社会成分的损害。虽然提供了支持性服务，但必须做出调整，以最佳地满足患者的需求。在新药物时代，进一步的研究应该检验不同干预措施对这些患者生活质量的生物心理社会成分的有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Haematologica 医学-血液学

CiteScore

4.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Acta Haematologica'' is a well-established and internationally recognized clinically-oriented journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in first-rate basic and clinical papers some of which are accompanied by editorial comments by eminent experts. These are supplemented by short state-of-the-art communications, reviews and correspondence as well as occasional special issues devoted to ‘hot topics’ in hematology. These will keep the practicing hematologist well informed of the new developments in the field.